Pityriasis amiantaceahttps://en.wikipedia.org/wiki/Pityriasis_amiantacea
Ko te Pityriasis amiantacea he mate kirikiri o te kiri mahunga, ka kuhu mai te unahi mau tonu. I te nuinga o ngā wā, kāore e puta he nāwai, he alopecia rānei.

Ko te pityriasis amiantacea ka pā ki te mahunga, he unahi matotoru kanapa. Ka tautokohia e ngā unahi, ka herea ki raro ngā rōpū o ngā makawe. Ka taea te ahuatanga te whakawhānui, ka hipoki rānei i te mahunga katoa. Ka puta pea te alopecia rangitahi me te alopecia nāwai nā te tango tonu o ngā makawe e piri ana ki te tauine. He mate onge.

Maimoatanga ― OTC Drugs
*Ka awhina pea ngā keratolytic e mau ana i te urea ki te rongoā i te tauine matotoru.
#40% urea cream

*Whakamahia te shampoo anti‑dandruff ia rā.
#Ciclopirox shampoo
#Ketoconazole shampoo
#Fluocinolone shampoo
#Pyrithione zinc shampoo
#Selenium sulfide shampoo

*Hoatu ngā steroids OTC ki ngā wāhi kirikiri o te mahunga. Kia mōhio koe, ko te tono nui rawa o te pūtaiaki ki te mahunga ka puta he folliculitis.
#Hydrocortisone cream
☆ AI Dermatology — Free Service
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
      References Pityriasis amiantacea - Case reports 25506575 
      NIH
      He tama 14‑tau te pakeke i uru mai me ngā unahi matotoru, kowhai‑parauri i runga i tōna mahunga, te nuinga o mua me runga. Ko ngā wāhi i pā he whero me te kirikiri, me ngā makawe ngaro, engari kāore he whiu. He kino ngā whakamātautau mō te harore.
      A 14-year-old male patient presented with focal masses of thick, adherent, plate like, yellow-brown scales, attached to the hair shafts, predominantly affecting the fronto-parietal area and vertex of the scalp. The underlying scalp had thick, erythematous plaques with fine, non greasy, silvery-white scaling with noncicatricial alopecia. Potassium hydroxide examination of scales and hair and culture for fungus was negative.
       Pityriasis amiantacea: a study of seven cases 27828657 
      NIH
      The disease may be secondary to any skin condition that primarily affects the scalp, including seborrheic dermatitis. Its pathogenesis remains uncertain. We aim to analyze the epidemiological and clinical profiles of patients with pityriasis amiantacea to better understand treatment responses. We identified seven cases of pityriasis amiantacea and a female predominance in a sample of 63 pediatric patients with seborrheic dermatitis followed for an average of 20.4 months. We reported a mean age of 5.9 years. Five patients were female, with a mean age of 9 years. All patients were successfully treated with topic ketoconazole.